Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06785935

Comparison Between 2 Treatment Modalities of Trigger Finger: Ultrasound-guided Percutaneous Release of A1 Pulley by a Needle Knife Versus Ultrasound-guided Corticosteroid Injection in the Treatment of Trigger Finger

Trigger finger is a common cause of hand disability and pain in the general population. It is a pathologic condition of the digital pulleys and flexor tendons. Although the pathogenesis is incompletely clear and multifactorial, the most common cause of the trigger finger is the thickened flexor tendon and/or thickened first annular (A1) pulley located at the metacarpophalangeal joint. Currently, ultrasound is considered an effective and valuable tool for assessing the trigger finger, providing static and dynamic evaluations of this condition and a comparison with the adjacent normal digits. Recently, it has been reported that ultrasound-guided percutaneous A1 pulley precise release using a needle knife has received increasing attention in the clinical treatment of trigger fingers and achieved good results. To our knowledge, this is the first clinical study comparing the efficacy and safety of ultrasonic-guided percutaneous A1 pulley release with a needle knife and the ultrasonic-guided steroid injection in treating trigger fingers.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura University Hospitals

Al Mansurah, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Idiopathic trigger finger
  • Trigger finger at the level of A1 pulley
  • Trigger finger of Green's grades II or III

Exclusion criteria

  • Patients with secondary causes of trigger fingers like diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, and sarcoidosis.
  • Patients with a previous history of first annular pulley release or injection.
  • Patients with trigger fingers of Green's grade I and IV.
  • Patients with trigger fingers at any level other than the A1 pulley.

Treatment and study plan

Needle knife

Device

ultrasonography-guided percutaneous A1 pulley release using a needle knife

Corticosteroid: Betamethasone

Drug

ultrasonography-guided corticosteroid injection under the A1 pulley

Primary outcomes

  1. Pain intensity using the visual analog scale (VAS) scoring system

    Time frame: Before the procedure as well as after one week, one month, and three months

  2. Functional ability according to the standard quick disabilities of the arm, shoulder, and hand score (Q DASH) questionnaire

    Time frame: Before the procedure as well as after one week, one month, and three months

  3. Recurrence: The grade of trigger finger according to Green's classification

    Time frame: Before the procedure as well as after one week, one month, and three months

  4. Complications such as inflammation, infection, scarring, wound healing problems, and sensory changes

    Time frame: After one week of the procedure

Sponsors and collaborators

Lead sponsor

Mansoura University Hospital

Other

Registry information

Official study title

Ultrasound-guided Percutaneous Release of A1 Pulley by a Needle Knife Versus Ultrasound-guided Corticosteroid Injection in the Treatment of Trigger Finger: a Randomized Clinical Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 21, 2025
Registry last updated
Jan 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.